PrEP could complement established HIV prevention strategies for pregnant and breastfeeding women as part of a comprehensive package to reduce HIV infections among women and transmission from mothers to infants in settings with high HIV incidence.
Pregnant women and HIV
Resource
October 26, 2018
Resource
August 23, 2018
Background: The recent scale-up of prevention of mother-to-child transmission of HIV (PMTCT) services has rapidly accelerated antiretroviral therapy (ART) uptake among pregnant and postpartum women in sub-Saharan Africa.
Resource
July 31, 2018
Background
Understanding the absolute and relative risk of human immunodeficiency virus type 1 (HIV) acquisition during pregnancy and the postpartum period can inform HIV prevention strategies for women.
Resource
July 9, 2018
INTRODUCTION:
Resource
July 9, 2018
Background
Resource
July 9, 2018
INTRODUCTION:
Resource
June 26, 2018
This article is featured in the SHARE Research Digest. Click here to learn more.
Resource
June 13, 2018
HIV acquisition during pregnancy and breastfeeding significantly contributes toward paediatric HIV infection; however, little is known about risk behaviours in HIV-uninfected pregnant and postpartum women.
News
May 29, 2018
Women with HIV who might become pregnant advised to avoid dolutegravir unless using effective contraception
News
May 23, 2018
A study among pregnant women in South Africa has found many lack control over condom use – and would be willing to use pre-exposure prophylaxis (PrEP) to protect themselves and their babies from HIV.
